Speakers 2023

Anthony de Buck van Overstraeten

Sine Buhl

Christianne Buskens
The Netherlands

Christianne Buskens graduated as a medical doctor in 1999. From 2000 until 2003 she worked as a research fellow at the department of surgery, and the department of experimental oncology at the Academic Medical Centre (AMC) in Amsterdam. This resulted in her PhD thesis ´The development of new treatment strategies for oesophageal cancer’, which she defended with distinction in 2004. She was trained as a surgeon from 2003 until 2009 at the AMC, Antoni van Leeuwenhoek Hospital (Amsterdam), and Gelre Hospitals (Apeldoorn). After completion of her surgical training, she was granted a fellowship from the Dutch Cancer Organization (KWF) at the department of colorectal surgery in Oxford, United Kingdom. Here, she specialized in proctology and minimally invasive surgery. To combine clinical work with (translational) research work, she completed a masters program in clinical epidemiology.

In January 2012, she became a staff member of the AMC colorectal surgeons group. Here, her field of interest changed from oncology to IBD. Today, she is a specialized IBD-surgeon treating this fascinating disease in all its complexity, in a multidisciplinary setting. She combines her clinical work with translational research which is funded by an innovative research incentive grant from The Netherlands organisation for health research and development. This grant enables her to spend dedicated research time in the laboratory, and was the basis for some ongoing translational IBD research lines: the role of the mesentery in Crohn’s disease, the role of the appendix in ulcerative colitis, and the fundamental characterization of perianal fistulas in Crohn’s patients.

Geert D’Haens
The Netherlands

Marietta Iacucci

Johan Ilvemark

Kristin Kaasen Jørgensen

Kaija-Leena Kolho

Christian Maaser

Fernando Magro

Miles Parkes
United Kingdom

Mattias Soop

Séverine Vermeire

Séverine Vermeire obtained her MD degree at the KU Leuven in 1995 and a PhD at the same University in 2001 on “Genetic Polymorphisms and Serologic Markers in Inflammatory Bowel Disease”. She further trained at the Universidad Nacional de Asuncion, Paraguay (1993), at the Wellcome Trust Centre for Human Genetics , University of Oxford (1997-1998) UK and at the Montreal General Hospital (McGill University) in Canada (2000–2001). Since 2003 she is staff member at the Gastroenterology Department of the University Hospitals Leuven and is appointed Full Professor of Medicine at the KU Leuven. Since 2016, she is Head of the De-partment of Chronic Diseases, Metabolism & Ageing (CHROMETA) at the KU Leuven.

Dr Vermeire is actively involved as principle investigator in RCTs with new therapeutic com-pounds and has been lead investigator on several of these programs. Her scientific work resulted in more than 500 peer-reviewed articles so far and focusses on the role of the mi-crobiome and genetic susceptibility in IBD and on identifying predictive signatures of treat-ment response. Dr Vermeire participated in the International iCHOM consortium on devel-opment of Patient-Centered Outcomes for Inflammatory Bowel Disease.

She was awarded several grants including an Advanced H2020-European Research Council (ERC) Grant (2016-2021) and a VIB Grand Challenges project on microbiota modulation strat-egies in Inflammatory Bowel Diseases together with Professor Jeroen Raes (2018)

Séverine Vermeire was President of the European Crohn’s and Colitis Organisation (ECCO) from 2014-2016 and of the Belgian IBD Research & Development (BIRD) Group from 2011-2013